StonvexLoading…
StonvexStonvexStonvexCore line items from SOLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $3.89B | $3.77B | $3.65B |
Operating Income | $647.00M | $797.00M | $814.00M |
Net Income | $237.00M | $594.00M | $621.00M |
EPS (Diluted) | $1.49 | $3.74 | $3.91 |
Total Assets | $5.67B | $5.00B | Not available |
Total Liabilities | $4.30B | $1.82B | Not available |
Cash & Equivalents | $534.00M | $661.00M | $606.00M |
Free Cash Flow OCF − CapEx | $119.00M | $546.00M | $461.00M |
Shares Outstanding | 158.75M | 0 | 158.70M |